PortfoliosLab logoPortfoliosLab logo
BMTX vs. TMDX
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

BMTX vs. TMDX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BM Technologies, Inc. (BMTX) and TransMedics Group, Inc. (TMDX). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

BMTX vs. TMDX - Yearly Performance Comparison


2026 (YTD)
BMTX
BM Technologies, Inc.
0.00%
TMDX
TransMedics Group, Inc.
-25.66%

Fundamentals

Total Revenue (TTM)

BMTX:

$57.66M

TMDX:

$605.49M

Gross Profit (TTM)

BMTX:

$14.95M

TMDX:

$362.81M

EBITDA (TTM)

BMTX:

-$6.70M

TMDX:

$137.31M

Returns By Period


BMTX

1D
0.00%
1M
0.00%
YTD
6M
1Y
3Y*
5Y*
10Y*

TMDX

1D
1.00%
1M
-31.70%
YTD
-17.47%
6M
-12.61%
1Y
47.06%
3Y*
9.86%
5Y*
20.17%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BMTX vs. TMDX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMTX

TMDX
TMDX Risk / Return Rank: 6868
Overall Rank
TMDX Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
TMDX Sortino Ratio Rank: 6969
Sortino Ratio Rank
TMDX Omega Ratio Rank: 6464
Omega Ratio Rank
TMDX Calmar Ratio Rank: 6868
Calmar Ratio Rank
TMDX Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BMTX vs. TMDX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BM Technologies, Inc. (BMTX) and TransMedics Group, Inc. (TMDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

BMTX vs. TMDX - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


BMTXTMDXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.83

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.28

Sharpe Ratio (All Time)

Calculated using the full available price history

0.34

Dividends

BMTX vs. TMDX - Dividend Comparison

Neither BMTX nor TMDX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BMTX vs. TMDX - Drawdown Comparison

The maximum BMTX drawdown since its inception was 0.00%, smaller than the maximum TMDX drawdown of -73.69%. Use the drawdown chart below to compare losses from any high point for BMTX and TMDX.


Loading graphics...

Drawdown Indicators


BMTXTMDXDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-73.69%

+73.69%

Max Drawdown (1Y)

Largest decline over 1 year

-37.30%

Max Drawdown (5Y)

Largest decline over 5 years

-68.60%

Current Drawdown

Current decline from peak

0.00%

-42.99%

+42.99%

Average Drawdown

Average peak-to-trough decline

0.00%

-31.36%

+31.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.77%

Volatility

BMTX vs. TMDX - Volatility Comparison


Loading graphics...

Volatility by Period


BMTXTMDXDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.90%

Volatility (6M)

Calculated over the trailing 6-month period

37.61%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

56.91%

-56.91%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

71.97%

-71.97%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

71.62%

-71.62%

Financials

BMTX vs. TMDX - Financials Comparison

This section allows you to compare key financial metrics between BM Technologies, Inc. and TransMedics Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
14.08M
160.76M
(BMTX) Total Revenue
(TMDX) Total Revenue
Values in USD except per share items